Product Description
Capnography (Phillips MP20 monitor) for Hypoxia (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01507623)
Mechanisms of Action:
Novel Mechanism: No
Modality: Unknown
Route of Administration: Nasal
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: University Hospital, Gentoftepenhagen
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01507623 |
NAPS | N/A |
Completed |
Hypoxia |
2011-02-01 |
2019-03-19 |
Treatments |